- call +1-201-465-4211
- email sales@marketquest.biz
- Call +1-201-465-4211
- Email: sales@marketquest.biz
Beta-Nicotinamide mononucleotide (NMN) is an intermediate of NAD+ biosynthesis produced from nicotinamide through nicotinamide phosphoribosyltransferase (NAMPT) and also referred to as NMN or nicotinamide ribotide.
According to our latest study, the global β-Nicotinamide Mononucleotide (NMN) market size was valued at USD 262.7 million in 2022 and is forecast to a readjusted size of USD 451.3 million by 2029 with a CAGR of 8.0% during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Global core β-nicotinamide mononucleotide (NMN) manufacturers include GeneHarbor, Herbalmax and Genex Formulas etc. The top 3 companies hold a share about 74%.Asia-Pacific is the largest market, with a share about 70%, followed by Americas with the share about 25%.
This report is a detailed and comprehensive analysis for global β-Nicotinamide Mononucleotide (NMN) market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Content and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global β-Nicotinamide Mononucleotide (NMN) market size and forecasts, in consumption value ($ Million), sales quantity (Kg), and average selling prices (US$/Kg), 2018-2029
Global β-Nicotinamide Mononucleotide (NMN) market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Kg), and average selling prices (US$/Kg), 2018-2029
Global β-Nicotinamide Mononucleotide (NMN) market size and forecasts, by Content and by Application, in consumption value ($ Million), sales quantity (Kg), and average selling prices (US$/Kg), 2018-2029
Global β-Nicotinamide Mononucleotide (NMN) market shares of main players, shipments in revenue ($ Million), sales quantity (Kg), and ASP (US$/Kg), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for β-Nicotinamide Mononucleotide (NMN)
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global β-Nicotinamide Mononucleotide (NMN) market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include GeneHarbor, Herbalmax, Genex Formulas, Shinkowa Pharmaceutical and Maac10 Formulas, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market Segmentation
β-Nicotinamide Mononucleotide (NMN) market is split by Content and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Content, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Content
Above 98%
Below 98%
Market segment by Application
Health Care Products
Cosmetics
Others
Major players covered
GeneHarbor
Herbalmax
Genex Formulas
Shinkowa Pharmaceutical
Maac10 Formulas
EffePharm
Bontac
CELFULL
Kingdomway
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe β-Nicotinamide Mononucleotide (NMN) product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of β-Nicotinamide Mononucleotide (NMN), with price, sales, revenue and global market share of β-Nicotinamide Mononucleotide (NMN) from 2018 to 2023.
Chapter 3, the β-Nicotinamide Mononucleotide (NMN) competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the β-Nicotinamide Mononucleotide (NMN) breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Content and application, with sales market share and growth rate by content, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and β-Nicotinamide Mononucleotide (NMN) market forecast, by regions, content and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of β-Nicotinamide Mononucleotide (NMN).
Chapter 14 and 15, to describe β-Nicotinamide Mononucleotide (NMN) sales channel, distributors, customers, research findings and conclusion.
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Market Overview
1.1 Product Overview and Scope of β-Nicotinamide Mononucleotide (NMN)
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Content
1.3.1 Overview: Global β-Nicotinamide Mononucleotide (NMN) Consumption Value by Content: 2018 Versus 2022 Versus 2029
1.3.2 Above 98%
1.3.3 Below 98%
1.4 Market Analysis by Application
1.4.1 Overview: Global β-Nicotinamide Mononucleotide (NMN) Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Health Care Products
1.4.3 Cosmetics
1.4.4 Others
1.5 Global β-Nicotinamide Mononucleotide (NMN) Market Size & Forecast
1.5.1 Global β-Nicotinamide Mononucleotide (NMN) Consumption Value (2018 & 2022 & 2029)
1.5.2 Global β-Nicotinamide Mononucleotide (NMN) Sales Quantity (2018-2029)
1.5.3 Global β-Nicotinamide Mononucleotide (NMN) Average Price (2018-2029)
2 Manufacturers Profiles
2.1 GeneHarbor
2.1.1 GeneHarbor Details
2.1.2 GeneHarbor Major Business
2.1.3 GeneHarbor β-Nicotinamide Mononucleotide (NMN) Product and Services
2.1.4 GeneHarbor β-Nicotinamide Mononucleotide (NMN) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 GeneHarbor Recent Developments/Updates
2.2 Herbalmax
2.2.1 Herbalmax Details
2.2.2 Herbalmax Major Business
2.2.3 Herbalmax β-Nicotinamide Mononucleotide (NMN) Product and Services
2.2.4 Herbalmax β-Nicotinamide Mononucleotide (NMN) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Herbalmax Recent Developments/Updates
2.3 Genex Formulas
2.3.1 Genex Formulas Details
2.3.2 Genex Formulas Major Business
2.3.3 Genex Formulas β-Nicotinamide Mononucleotide (NMN) Product and Services
2.3.4 Genex Formulas β-Nicotinamide Mononucleotide (NMN) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Genex Formulas Recent Developments/Updates
2.4 Shinkowa Pharmaceutical
2.4.1 Shinkowa Pharmaceutical Details
2.4.2 Shinkowa Pharmaceutical Major Business
2.4.3 Shinkowa Pharmaceutical β-Nicotinamide Mononucleotide (NMN) Product and Services
2.4.4 Shinkowa Pharmaceutical β-Nicotinamide Mononucleotide (NMN) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Shinkowa Pharmaceutical Recent Developments/Updates
2.5 Maac10 Formulas
2.5.1 Maac10 Formulas Details
2.5.2 Maac10 Formulas Major Business
2.5.3 Maac10 Formulas β-Nicotinamide Mononucleotide (NMN) Product and Services
2.5.4 Maac10 Formulas β-Nicotinamide Mononucleotide (NMN) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Maac10 Formulas Recent Developments/Updates
2.6 EffePharm
2.6.1 EffePharm Details
2.6.2 EffePharm Major Business
2.6.3 EffePharm β-Nicotinamide Mononucleotide (NMN) Product and Services
2.6.4 EffePharm β-Nicotinamide Mononucleotide (NMN) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 EffePharm Recent Developments/Updates
2.7 Bontac
2.7.1 Bontac Details
2.7.2 Bontac Major Business
2.7.3 Bontac β-Nicotinamide Mononucleotide (NMN) Product and Services
2.7.4 Bontac β-Nicotinamide Mononucleotide (NMN) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Bontac Recent Developments/Updates
2.8 CELFULL
2.8.1 CELFULL Details
2.8.2 CELFULL Major Business
2.8.3 CELFULL β-Nicotinamide Mononucleotide (NMN) Product and Services
2.8.4 CELFULL β-Nicotinamide Mononucleotide (NMN) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 CELFULL Recent Developments/Updates
2.9 Kingdomway
2.9.1 Kingdomway Details
2.9.2 Kingdomway Major Business
2.9.3 Kingdomway β-Nicotinamide Mononucleotide (NMN) Product and Services
2.9.4 Kingdomway β-Nicotinamide Mononucleotide (NMN) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Kingdomway Recent Developments/Updates
3 Competitive Environment: β-Nicotinamide Mononucleotide (NMN) by Manufacturer
3.1 Global β-Nicotinamide Mononucleotide (NMN) Sales Quantity by Manufacturer (2018-2023)
3.2 Global β-Nicotinamide Mononucleotide (NMN) Revenue by Manufacturer (2018-2023)
3.3 Global β-Nicotinamide Mononucleotide (NMN) Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of β-Nicotinamide Mononucleotide (NMN) by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 β-Nicotinamide Mononucleotide (NMN) Manufacturer Market Share in 2022
3.4.2 Top 6 β-Nicotinamide Mononucleotide (NMN) Manufacturer Market Share in 2022
3.5 β-Nicotinamide Mononucleotide (NMN) Market: Overall Company Footprint Analysis
3.5.1 β-Nicotinamide Mononucleotide (NMN) Market: Region Footprint
3.5.2 β-Nicotinamide Mononucleotide (NMN) Market: Company Product Type Footprint
3.5.3 β-Nicotinamide Mononucleotide (NMN) Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
4.1 Global β-Nicotinamide Mononucleotide (NMN) Market Size by Region
4.1.1 Global β-Nicotinamide Mononucleotide (NMN) Sales Quantity by Region (2018-2029)
4.1.2 Global β-Nicotinamide Mononucleotide (NMN) Consumption Value by Region (2018-2029)
4.1.3 Global β-Nicotinamide Mononucleotide (NMN) Average Price by Region (2018-2029)
4.2 North America β-Nicotinamide Mononucleotide (NMN) Consumption Value (2018-2029)
4.3 Europe β-Nicotinamide Mononucleotide (NMN) Consumption Value (2018-2029)
4.4 Asia-Pacific β-Nicotinamide Mononucleotide (NMN) Consumption Value (2018-2029)
4.5 South America β-Nicotinamide Mononucleotide (NMN) Consumption Value (2018-2029)
4.6 Middle East and Africa β-Nicotinamide Mononucleotide (NMN) Consumption Value (2018-2029)
5 Market Segment by Content
5.1 Global β-Nicotinamide Mononucleotide (NMN) Sales Quantity by Content (2018-2029)
5.2 Global β-Nicotinamide Mononucleotide (NMN) Consumption Value by Content (2018-2029)
5.3 Global β-Nicotinamide Mononucleotide (NMN) Average Price by Content (2018-2029)
6 Market Segment by Application
6.1 Global β-Nicotinamide Mononucleotide (NMN) Sales Quantity by Application (2018-2029)
6.2 Global β-Nicotinamide Mononucleotide (NMN) Consumption Value by Application (2018-2029)
6.3 Global β-Nicotinamide Mononucleotide (NMN) Average Price by Application (2018-2029)
7 North America
7.1 North America β-Nicotinamide Mononucleotide (NMN) Sales Quantity by Content (2018-2029)
7.2 North America β-Nicotinamide Mononucleotide (NMN) Sales Quantity by Application (2018-2029)
7.3 North America β-Nicotinamide Mononucleotide (NMN) Market Size by Country
7.3.1 North America β-Nicotinamide Mononucleotide (NMN) Sales Quantity by Country (2018-2029)
7.3.2 North America β-Nicotinamide Mononucleotide (NMN) Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 Europe
8.1 Europe β-Nicotinamide Mononucleotide (NMN) Sales Quantity by Content (2018-2029)
8.2 Europe β-Nicotinamide Mononucleotide (NMN) Sales Quantity by Application (2018-2029)
8.3 Europe β-Nicotinamide Mononucleotide (NMN) Market Size by Country
8.3.1 Europe β-Nicotinamide Mononucleotide (NMN) Sales Quantity by Country (2018-2029)
8.3.2 Europe β-Nicotinamide Mononucleotide (NMN) Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 Asia-Pacific
9.1 Asia-Pacific β-Nicotinamide Mononucleotide (NMN) Sales Quantity by Content (2018-2029)
9.2 Asia-Pacific β-Nicotinamide Mononucleotide (NMN) Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific β-Nicotinamide Mononucleotide (NMN) Market Size by Region
9.3.1 Asia-Pacific β-Nicotinamide Mononucleotide (NMN) Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific β-Nicotinamide Mononucleotide (NMN) Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 South America
10.1 South America β-Nicotinamide Mononucleotide (NMN) Sales Quantity by Content (2018-2029)
10.2 South America β-Nicotinamide Mononucleotide (NMN) Sales Quantity by Application (2018-2029)
10.3 South America β-Nicotinamide Mononucleotide (NMN) Market Size by Country
10.3.1 South America β-Nicotinamide Mononucleotide (NMN) Sales Quantity by Country (2018-2029)
10.3.2 South America β-Nicotinamide Mononucleotide (NMN) Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 Middle East & Africa
11.1 Middle East & Africa β-Nicotinamide Mononucleotide (NMN) Sales Quantity by Content (2018-2029)
11.2 Middle East & Africa β-Nicotinamide Mononucleotide (NMN) Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa β-Nicotinamide Mononucleotide (NMN) Market Size by Country
11.3.1 Middle East & Africa β-Nicotinamide Mononucleotide (NMN) Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa β-Nicotinamide Mononucleotide (NMN) Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 Market Dynamics
12.1 β-Nicotinamide Mononucleotide (NMN) Market Drivers
12.2 β-Nicotinamide Mononucleotide (NMN) Market Restraints
12.3 β-Nicotinamide Mononucleotide (NMN) Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13 Raw Material and Industry Chain
13.1 Raw Material of β-Nicotinamide Mononucleotide (NMN) and Key Manufacturers
13.2 Manufacturing Costs Percentage of β-Nicotinamide Mononucleotide (NMN)
13.3 β-Nicotinamide Mononucleotide (NMN) Production Process
13.4 β-Nicotinamide Mononucleotide (NMN) Industrial Chain
14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 β-Nicotinamide Mononucleotide (NMN) Typical Distributors
14.3 β-Nicotinamide Mononucleotide (NMN) Typical Customers
15 Research Findings and Conclusion
16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
List of Tables
Table 1. Global β-Nicotinamide Mononucleotide (NMN) Consumption Value by Content, (USD Million), 2018 & 2022 & 2029
Table 2. Global β-Nicotinamide Mononucleotide (NMN) Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. GeneHarbor Basic Information, Manufacturing Base and Competitors
Table 4. GeneHarbor Major Business
Table 5. GeneHarbor β-Nicotinamide Mononucleotide (NMN) Product and Services
Table 6. GeneHarbor β-Nicotinamide Mononucleotide (NMN) Sales Quantity (Kg), Average Price (US$/Kg), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 7. GeneHarbor Recent Developments/Updates
Table 8. Herbalmax Basic Information, Manufacturing Base and Competitors
Table 9. Herbalmax Major Business
Table 10. Herbalmax β-Nicotinamide Mononucleotide (NMN) Product and Services
Table 11. Herbalmax β-Nicotinamide Mononucleotide (NMN) Sales Quantity (Kg), Average Price (US$/Kg), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 12. Herbalmax Recent Developments/Updates
Table 13. Genex Formulas Basic Information, Manufacturing Base and Competitors
Table 14. Genex Formulas Major Business
Table 15. Genex Formulas β-Nicotinamide Mononucleotide (NMN) Product and Services
Table 16. Genex Formulas β-Nicotinamide Mononucleotide (NMN) Sales Quantity (Kg), Average Price (US$/Kg), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 17. Genex Formulas Recent Developments/Updates
Table 18. Shinkowa Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 19. Shinkowa Pharmaceutical Major Business
Table 20. Shinkowa Pharmaceutical β-Nicotinamide Mononucleotide (NMN) Product and Services
Table 21. Shinkowa Pharmaceutical β-Nicotinamide Mononucleotide (NMN) Sales Quantity (Kg), Average Price (US$/Kg), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 22. Shinkowa Pharmaceutical Recent Developments/Updates
Table 23. Maac10 Formulas Basic Information, Manufacturing Base and Competitors
Table 24. Maac10 Formulas Major Business
Table 25. Maac10 Formulas β-Nicotinamide Mononucleotide (NMN) Product and Services
Table 26. Maac10 Formulas β-Nicotinamide Mononucleotide (NMN) Sales Quantity (Kg), Average Price (US$/Kg), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 27. Maac10 Formulas Recent Developments/Updates
Table 28. EffePharm Basic Information, Manufacturing Base and Competitors
Table 29. EffePharm Major Business
Table 30. EffePharm β-Nicotinamide Mononucleotide (NMN) Product and Services
Table 31. EffePharm β-Nicotinamide Mononucleotide (NMN) Sales Quantity (Kg), Average Price (US$/Kg), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 32. EffePharm Recent Developments/Updates
Table 33. Bontac Basic Information, Manufacturing Base and Competitors
Table 34. Bontac Major Business
Table 35. Bontac β-Nicotinamide Mononucleotide (NMN) Product and Services
Table 36. Bontac β-Nicotinamide Mononucleotide (NMN) Sales Quantity (Kg), Average Price (US$/Kg), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 37. Bontac Recent Developments/Updates
Table 38. CELFULL Basic Information, Manufacturing Base and Competitors
Table 39. CELFULL Major Business
Table 40. CELFULL β-Nicotinamide Mononucleotide (NMN) Product and Services
Table 41. CELFULL β-Nicotinamide Mononucleotide (NMN) Sales Quantity (Kg), Average Price (US$/Kg), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 42. CELFULL Recent Developments/Updates
Table 43. Kingdomway Basic Information, Manufacturing Base and Competitors
Table 44. Kingdomway Major Business
Table 45. Kingdomway β-Nicotinamide Mononucleotide (NMN) Product and Services
Table 46. Kingdomway β-Nicotinamide Mononucleotide (NMN) Sales Quantity (Kg), Average Price (US$/Kg), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 47. Kingdomway Recent Developments/Updates
Table 48. Global β-Nicotinamide Mononucleotide (NMN) Sales Quantity by Manufacturer (2018-2023) & (Kg)
Table 49. Global β-Nicotinamide Mononucleotide (NMN) Revenue by Manufacturer (2018-2023) & (USD Million)
Table 50. Global β-Nicotinamide Mononucleotide (NMN) Average Price by Manufacturer (2018-2023) & (US$/Kg)
Table 51. Market Position of Manufacturers in β-Nicotinamide Mononucleotide (NMN), (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
Table 52. Head Office and β-Nicotinamide Mononucleotide (NMN) Production Site of Key Manufacturer
Table 53. β-Nicotinamide Mononucleotide (NMN) Market: Company Product Type Footprint
Table 54. β-Nicotinamide Mononucleotide (NMN) Market: Company Product Application Footprint
Table 55. β-Nicotinamide Mononucleotide (NMN) New Market Entrants and Barriers to Market Entry
Table 56. β-Nicotinamide Mononucleotide (NMN) Mergers, Acquisition, Agreements, and Collaborations
Table 57. Global β-Nicotinamide Mononucleotide (NMN) Sales Quantity by Region (2018-2023) & (Kg)
Table 58. Global β-Nicotinamide Mononucleotide (NMN) Sales Quantity by Region (2024-2029) & (Kg)
Table 59. Global β-Nicotinamide Mononucleotide (NMN) Consumption Value by Region (2018-2023) & (USD Million)
Table 60. Global β-Nicotinamide Mononucleotide (NMN) Consumption Value by Region (2024-2029) & (USD Million)
Table 61. Global β-Nicotinamide Mononucleotide (NMN) Average Price by Region (2018-2023) & (US$/Kg)
Table 62. Global β-Nicotinamide Mononucleotide (NMN) Average Price by Region (2024-2029) & (US$/Kg)
Table 63. Global β-Nicotinamide Mononucleotide (NMN) Sales Quantity by Content (2018-2023) & (Kg)
Table 64. Global β-Nicotinamide Mononucleotide (NMN) Sales Quantity by Content (2024-2029) & (Kg)
Table 65. Global β-Nicotinamide Mononucleotide (NMN) Consumption Value by Content (2018-2023) & (USD Million)
Table 66. Global β-Nicotinamide Mononucleotide (NMN) Consumption Value by Content (2024-2029) & (USD Million)
Table 67. Global β-Nicotinamide Mononucleotide (NMN) Average Price by Content (2018-2023) & (US$/Kg)
Table 68. Global β-Nicotinamide Mononucleotide (NMN) Average Price by Content (2024-2029) & (US$/Kg)
Table 69. Global β-Nicotinamide Mononucleotide (NMN) Sales Quantity by Application (2018-2023) & (Kg)
Table 70. Global β-Nicotinamide Mononucleotide (NMN) Sales Quantity by Application (2024-2029) & (Kg)
Table 71. Global β-Nicotinamide Mononucleotide (NMN) Consumption Value by Application (2018-2023) & (USD Million)
Table 72. Global β-Nicotinamide Mononucleotide (NMN) Consumption Value by Application (2024-2029) & (USD Million)
Table 73. Global β-Nicotinamide Mononucleotide (NMN) Average Price by Application (2018-2023) & (US$/Kg)
Table 74. Global β-Nicotinamide Mononucleotide (NMN) Average Price by Application (2024-2029) & (US$/Kg)
Table 75. North America β-Nicotinamide Mononucleotide (NMN) Sales Quantity by Content (2018-2023) & (Kg)
Table 76. North America β-Nicotinamide Mononucleotide (NMN) Sales Quantity by Content (2024-2029) & (Kg)
Table 77. North America β-Nicotinamide Mononucleotide (NMN) Sales Quantity by Application (2018-2023) & (Kg)
Table 78. North America β-Nicotinamide Mononucleotide (NMN) Sales Quantity by Application (2024-2029) & (Kg)
Table 79. North America β-Nicotinamide Mononucleotide (NMN) Sales Quantity by Country (2018-2023) & (Kg)
Table 80. North America β-Nicotinamide Mononucleotide (NMN) Sales Quantity by Country (2024-2029) & (Kg)
Table 81. North America β-Nicotinamide Mononucleotide (NMN) Consumption Value by Country (2018-2023) & (USD Million)
Table 82. North America β-Nicotinamide Mononucleotide (NMN) Consumption Value by Country (2024-2029) & (USD Million)
Table 83. Europe β-Nicotinamide Mononucleotide (NMN) Sales Quantity by Content (2018-2023) & (Kg)
Table 84. Europe β-Nicotinamide Mononucleotide (NMN) Sales Quantity by Content (2024-2029) & (Kg)
Table 85. Europe β-Nicotinamide Mononucleotide (NMN) Sales Quantity by Application (2018-2023) & (Kg)
Table 86. Europe β-Nicotinamide Mononucleotide (NMN) Sales Quantity by Application (2024-2029) & (Kg)
Table 87. Europe β-Nicotinamide Mononucleotide (NMN) Sales Quantity by Country (2018-2023) & (Kg)
Table 88. Europe β-Nicotinamide Mononucleotide (NMN) Sales Quantity by Country (2024-2029) & (Kg)
Table 89. Europe β-Nicotinamide Mononucleotide (NMN) Consumption Value by Country (2018-2023) & (USD Million)
Table 90. Europe β-Nicotinamide Mononucleotide (NMN) Consumption Value by Country (2024-2029) & (USD Million)
Table 91. Asia-Pacific β-Nicotinamide Mononucleotide (NMN) Sales Quantity by Content (2018-2023) & (Kg)
Table 92. Asia-Pacific β-Nicotinamide Mononucleotide (NMN) Sales Quantity by Content (2024-2029) & (Kg)
Table 93. Asia-Pacific β-Nicotinamide Mononucleotide (NMN) Sales Quantity by Application (2018-2023) & (Kg)
Table 94. Asia-Pacific β-Nicotinamide Mononucleotide (NMN) Sales Quantity by Application (2024-2029) & (Kg)
Table 95. Asia-Pacific β-Nicotinamide Mononucleotide (NMN) Sales Quantity by Region (2018-2023) & (Kg)
Table 96. Asia-Pacific β-Nicotinamide Mononucleotide (NMN) Sales Quantity by Region (2024-2029) & (Kg)
Table 97. Asia-Pacific β-Nicotinamide Mononucleotide (NMN) Consumption Value by Region (2018-2023) & (USD Million)
Table 98. Asia-Pacific β-Nicotinamide Mononucleotide (NMN) Consumption Value by Region (2024-2029) & (USD Million)
Table 99. South America β-Nicotinamide Mononucleotide (NMN) Sales Quantity by Content (2018-2023) & (Kg)
Table 100. South America β-Nicotinamide Mononucleotide (NMN) Sales Quantity by Content (2024-2029) & (Kg)
Table 101. South America β-Nicotinamide Mononucleotide (NMN) Sales Quantity by Application (2018-2023) & (Kg)
Table 102. South America β-Nicotinamide Mononucleotide (NMN) Sales Quantity by Application (2024-2029) & (Kg)
Table 103. South America β-Nicotinamide Mononucleotide (NMN) Sales Quantity by Country (2018-2023) & (Kg)
Table 104. South America β-Nicotinamide Mononucleotide (NMN) Sales Quantity by Country (2024-2029) & (Kg)
Table 105. South America β-Nicotinamide Mononucleotide (NMN) Consumption Value by Country (2018-2023) & (USD Million)
Table 106. South America β-Nicotinamide Mononucleotide (NMN) Consumption Value by Country (2024-2029) & (USD Million)
Table 107. Middle East & Africa β-Nicotinamide Mononucleotide (NMN) Sales Quantity by Content (2018-2023) & (Kg)
Table 108. Middle East & Africa β-Nicotinamide Mononucleotide (NMN) Sales Quantity by Content (2024-2029) & (Kg)
Table 109. Middle East & Africa β-Nicotinamide Mononucleotide (NMN) Sales Quantity by Application (2018-2023) & (Kg)
Table 110. Middle East & Africa β-Nicotinamide Mononucleotide (NMN) Sales Quantity by Application (2024-2029) & (Kg)
Table 111. Middle East & Africa β-Nicotinamide Mononucleotide (NMN) Sales Quantity by Region (2018-2023) & (Kg)
Table 112. Middle East & Africa β-Nicotinamide Mononucleotide (NMN) Sales Quantity by Region (2024-2029) & (Kg)
Table 113. Middle East & Africa β-Nicotinamide Mononucleotide (NMN) Consumption Value by Region (2018-2023) & (USD Million)
Table 114. Middle East & Africa β-Nicotinamide Mononucleotide (NMN) Consumption Value by Region (2024-2029) & (USD Million)
Table 115. β-Nicotinamide Mononucleotide (NMN) Raw Material
Table 116. Key Manufacturers of β-Nicotinamide Mononucleotide (NMN) Raw Materials
Table 117. β-Nicotinamide Mononucleotide (NMN) Typical Distributors
Table 118. β-Nicotinamide Mononucleotide (NMN) Typical Customers
List of Figures
Figure 1. β-Nicotinamide Mononucleotide (NMN) Picture
Figure 2. Global β-Nicotinamide Mononucleotide (NMN) Consumption Value by Content, (USD Million), 2018 & 2022 & 2029
Figure 3. Global β-Nicotinamide Mononucleotide (NMN) Consumption Value Market Share by Content in 2022
Figure 4. Above 98% Examples
Figure 5. Below 98% Examples
Figure 6. Global β-Nicotinamide Mononucleotide (NMN) Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 7. Global β-Nicotinamide Mononucleotide (NMN) Consumption Value Market Share by Application in 2022
Figure 8. Health Care Products Examples
Figure 9. Cosmetics Examples
Figure 10. Others Examples
Figure 11. Global β-Nicotinamide Mononucleotide (NMN) Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 12. Global β-Nicotinamide Mononucleotide (NMN) Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 13. Global β-Nicotinamide Mononucleotide (NMN) Sales Quantity (2018-2029) & (Kg)
Figure 14. Global β-Nicotinamide Mononucleotide (NMN) Average Price (2018-2029) & (US$/Kg)
Figure 15. Global β-Nicotinamide Mononucleotide (NMN) Sales Quantity Market Share by Manufacturer in 2022
Figure 16. Global β-Nicotinamide Mononucleotide (NMN) Consumption Value Market Share by Manufacturer in 2022
Figure 17. Producer Shipments of β-Nicotinamide Mononucleotide (NMN) by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
Figure 18. Top 3 β-Nicotinamide Mononucleotide (NMN) Manufacturer (Consumption Value) Market Share in 2022
Figure 19. Top 6 β-Nicotinamide Mononucleotide (NMN) Manufacturer (Consumption Value) Market Share in 2022
Figure 20. Global β-Nicotinamide Mononucleotide (NMN) Sales Quantity Market Share by Region (2018-2029)
Figure 21. Global β-Nicotinamide Mononucleotide (NMN) Consumption Value Market Share by Region (2018-2029)
Figure 22. North America β-Nicotinamide Mononucleotide (NMN) Consumption Value (2018-2029) & (USD Million)
Figure 23. Europe β-Nicotinamide Mononucleotide (NMN) Consumption Value (2018-2029) & (USD Million)
Figure 24. Asia-Pacific β-Nicotinamide Mononucleotide (NMN) Consumption Value (2018-2029) & (USD Million)
Figure 25. South America β-Nicotinamide Mononucleotide (NMN) Consumption Value (2018-2029) & (USD Million)
Figure 26. Middle East & Africa β-Nicotinamide Mononucleotide (NMN) Consumption Value (2018-2029) & (USD Million)
Figure 27. Global β-Nicotinamide Mononucleotide (NMN) Sales Quantity Market Share by Content (2018-2029)
Figure 28. Global β-Nicotinamide Mononucleotide (NMN) Consumption Value Market Share by Content (2018-2029)
Figure 29. Global β-Nicotinamide Mononucleotide (NMN) Average Price by Content (2018-2029) & (US$/Kg)
Figure 30. Global β-Nicotinamide Mononucleotide (NMN) Sales Quantity Market Share by Application (2018-2029)
Figure 31. Global β-Nicotinamide Mononucleotide (NMN) Consumption Value Market Share by Application (2018-2029)
Figure 32. Global β-Nicotinamide Mononucleotide (NMN) Average Price by Application (2018-2029) & (US$/Kg)
Figure 33. North America β-Nicotinamide Mononucleotide (NMN) Sales Quantity Market Share by Content (2018-2029)
Figure 34. North America β-Nicotinamide Mononucleotide (NMN) Sales Quantity Market Share by Application (2018-2029)
Figure 35. North America β-Nicotinamide Mononucleotide (NMN) Sales Quantity Market Share by Country (2018-2029)
Figure 36. North America β-Nicotinamide Mononucleotide (NMN) Consumption Value Market Share by Country (2018-2029)
Figure 37. United States β-Nicotinamide Mononucleotide (NMN) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 38. Canada β-Nicotinamide Mononucleotide (NMN) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 39. Mexico β-Nicotinamide Mononucleotide (NMN) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 40. Europe β-Nicotinamide Mononucleotide (NMN) Sales Quantity Market Share by Content (2018-2029)
Figure 41. Europe β-Nicotinamide Mononucleotide (NMN) Sales Quantity Market Share by Application (2018-2029)
Figure 42. Europe β-Nicotinamide Mononucleotide (NMN) Sales Quantity Market Share by Country (2018-2029)
Figure 43. Europe β-Nicotinamide Mononucleotide (NMN) Consumption Value Market Share by Country (2018-2029)
Figure 44. Germany β-Nicotinamide Mononucleotide (NMN) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 45. France β-Nicotinamide Mononucleotide (NMN) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 46. United Kingdom β-Nicotinamide Mononucleotide (NMN) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 47. Russia β-Nicotinamide Mononucleotide (NMN) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 48. Italy β-Nicotinamide Mononucleotide (NMN) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 49. Asia-Pacific β-Nicotinamide Mononucleotide (NMN) Sales Quantity Market Share by Content (2018-2029)
Figure 50. Asia-Pacific β-Nicotinamide Mononucleotide (NMN) Sales Quantity Market Share by Application (2018-2029)
Figure 51. Asia-Pacific β-Nicotinamide Mononucleotide (NMN) Sales Quantity Market Share by Region (2018-2029)
Figure 52. Asia-Pacific β-Nicotinamide Mononucleotide (NMN) Consumption Value Market Share by Region (2018-2029)
Figure 53. China β-Nicotinamide Mononucleotide (NMN) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 54. Japan β-Nicotinamide Mononucleotide (NMN) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 55. Korea β-Nicotinamide Mononucleotide (NMN) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 56. India β-Nicotinamide Mononucleotide (NMN) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 57. Southeast Asia β-Nicotinamide Mononucleotide (NMN) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 58. Australia β-Nicotinamide Mononucleotide (NMN) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 59. South America β-Nicotinamide Mononucleotide (NMN) Sales Quantity Market Share by Content (2018-2029)
Figure 60. South America β-Nicotinamide Mononucleotide (NMN) Sales Quantity Market Share by Application (2018-2029)
Figure 61. South America β-Nicotinamide Mononucleotide (NMN) Sales Quantity Market Share by Country (2018-2029)
Figure 62. South America β-Nicotinamide Mononucleotide (NMN) Consumption Value Market Share by Country (2018-2029)
Figure 63. Brazil β-Nicotinamide Mononucleotide (NMN) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 64. Argentina β-Nicotinamide Mononucleotide (NMN) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 65. Middle East & Africa β-Nicotinamide Mononucleotide (NMN) Sales Quantity Market Share by Content (2018-2029)
Figure 66. Middle East & Africa β-Nicotinamide Mononucleotide (NMN) Sales Quantity Market Share by Application (2018-2029)
Figure 67. Middle East & Africa β-Nicotinamide Mononucleotide (NMN) Sales Quantity Market Share by Region (2018-2029)
Figure 68. Middle East & Africa β-Nicotinamide Mononucleotide (NMN) Consumption Value Market Share by Region (2018-2029)
Figure 69. Turkey β-Nicotinamide Mononucleotide (NMN) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 70. Egypt β-Nicotinamide Mononucleotide (NMN) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 71. Saudi Arabia β-Nicotinamide Mononucleotide (NMN) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 72. South Africa β-Nicotinamide Mononucleotide (NMN) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 73. β-Nicotinamide Mononucleotide (NMN) Market Drivers
Figure 74. β-Nicotinamide Mononucleotide (NMN) Market Restraints
Figure 75. β-Nicotinamide Mononucleotide (NMN) Market Trends
Figure 76. Porters Five Forces Analysis
Figure 77. Manufacturing Cost Structure Analysis of β-Nicotinamide Mononucleotide (NMN) in 2022
Figure 78. Manufacturing Process Analysis of β-Nicotinamide Mononucleotide (NMN)
Figure 79. β-Nicotinamide Mononucleotide (NMN) Industrial Chain
Figure 80. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 81. Direct Channel Pros & Cons
Figure 82. Indirect Channel Pros & Cons
Figure 83. Methodology
Figure 84. Research Process and Data Source
Please feel free to write an email to us or to use our electronic ticketing system.
